For patients who are overweight or obese, glucagonlike peptide 1 (GLP-1) and dual GLP-1/ gastric inhibitory polypeptide (GIP) agonists are the preferred adjunct or second-line treatments
5 Plus, given the critical role glutathione plays at the cellular and mitochondrial levels, the overall health and longevity benefits are vast and wide
Tirzepatides SURPASS programme demonstrated superior HbA1c reductions compared to semaglutide in head-to-head type 2 diabetes trials [2]
If you're managing side effects, experiencing cost constraints, or seeking dosing flexibility, a qualified healthcare provider can evaluate your medical history, current biomarkers, and genetic predispositions to GLP-1 sensitivity
AOD 9604 is a synthetic peptide derived from the C-terminus of human growth hormone
10.1159/000077996 32 JainC